We know/think so far , that Leronlimab is complementary with most cancer treatment ...

Chemotherapy - with CCR5 help DNA of cancer cell recuperate much faster , and patient with time developing resistance to it ...

Patients developing often resistance in about 6 months to immunotherapy , and we know about all those severe side effects with check point inhibitors ..

According to Dr Patterson , CCR5 inhibitors helping with all those problems , preventing many side effects , and preventing developing resistance ...

And so far IMO , the best from all CCR5 inhibitors is Leronlimab...

So actually look that all those other drugs will benefit when Leronlimab will be added to treatment..
We don't know yet if Leronlimab effect will be much better with other combinations ...or can be use solo...
I am sure studies will be done in the future to prove or disprove all those theories...

Those are theories , but theories base on detail research...

2 CC ago someone asked about CAR-T treatment , we know it is a very dangerous treatment , with the best care still about 15% mortality..
and Dr Patterson stated that here also Leronlimab could help ..

Look that we have very unusual drug here !




All IMO.